Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains

Journal of General Virology

Volumn 88, Issue 10, 2007, Pages 2702-2709

  Herfst, Sander ^a   de Graaf, Miranda ^a   Schrauwen, Eefje J A ^a   Ulbrandt, Nancy D ^b   Barnes, Arnita S ^b   Senthil, Kannaki ^b   Osterhaus, Albert D M E ^a   Fouchier, Ron A M ^a   van den Hoogen, Bernadette G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN METAPNEUMOVIRUS VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT VIRUS FUSION PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN METAPNEUMOVIRUS; IMMUNIZATION; IMMUNOGENICITY; LOWER RESPIRATORY TRACT INFECTION; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS INFECTION; STRAIN DIFFERENCE; SYRIAN HAMSTER; TURBINATE; VIRUS IMMUNITY; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CHILD; CRICETINAE; HAPLORHINI; HUMANS; MESOCRICETUS; METAPNEUMOVIRUS; MOLECULAR SEQUENCE DATA; PLASMIDS; RESPIRATORY TRACT INFECTIONS; RESTRICTION MAPPING; SPECIES SPECIFICITY; VERO CELLS; VIRAL PROTEINS; VIRAL VACCINES;

ANIMALIA; CRICETINAE; HUMAN METAPNEUMOVIRUS; MESOCRICETUS AURATUS; PARAMYXOVIRIDAE;

EID: 35048829250     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83084-0     Document Type: Article

References (38)

1. al-Shakhshir, R., Regnier, F., White, J. L. & Hem, S. L. (1994). Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants. Vaccine 12, 472-474.
2. Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D. & Yarranton, G. T. (1992). High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (N Y) 10, 169-175.
3. Beck I., Gerlach, H., Burkhardt, E. & Kaleta, E. F. (2003). Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3. Vaccine 21, 1006-1022.
4. Cseke, G., Wright, D. W., Tollefson, S. J., Johnson, J. E., Crowe, J. E., Jr & Williams, J. V. (2007). Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol 81, 698-707.
5. Davis, I. D., Chen, W., Jackson, H., Parente, P., Shackleton, M., Hopkins, W., Chen, Q., Dimopoulos, N., Luke, T. & other authors (2004). Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4 + and CD8 + T cell responses in humans. Proc Natl Acad Sci U S A 101, 10697-10702.
6. Deng, X., Meyers, S. A., Tollner, T. L., Yudin, A. I., Primakoff, P. D., He, D. N. & Overstreet J. W. (2002). Immunological response of female macaques to the PH-20 sperm protein following injection of recombinant proteins or synthesized peptides. J Reprod Immunol 54, 93-115.
7. Falsey, A. R. & Walsh, E. E. (1996). Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. Vaccine 14, 1214-1218.
8. Frazer, I. H., Quinn, M., Nicklin, J. L., Tan, J., Perrin, L. C., Ng, P., O'Connor, V. M., White, O., Wendt, N. & other authors (2004). Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. Vaccine 23, 172-181.
9. Gupta, R. K. (1998). Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 32, 155-172.
10. Hancock, G. E, Smith, J. D. & Heers, K. M. (2000). Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus. J Infect Dis 181, 1768-1771.
11. Herfst, S., de Graaf, M., Schickli, J. H., Tang, R. S., Kaur, J., Yang, C. F., Spaete, R. R., Haller, A. A., van den Hoogen, B. G. & other authors (2004). Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA. J Virol 78, 8264-8270.
12. Kim, H. W., Canchola, J. G., Brandt, C. D., Pyles, G., Chanock, R. M., Jensen, K. & Parrott, R. H. (1969). Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivate vaccine. Am J Epidemiol 89, 422-434.
13. Kuiken, T., Van Den Hoogen, B. G., Van Riel, D. A., Laman, J. D., Van Amerongen, G., Sprong, L., Fouchier, R. A. & Osterhaus, A. D. (2004). Experimental human metapneumovirus infection of cynomolgus macaques ( Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol 164, 1893-1900.
14. Lamb, R. A., Paterson, R. G. & Jardetzky, T. S. (2006). Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 344, 30-37.
15. Leenaars, P. P., Hendriksen, C. F., Angulo, A. F., Koedam, M. A. & Claassen, E. (1994). Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits. Vet Immunol Immunopathol 40, 225-241.
16. Lindblad, E. B. (2004). Aluminium compounds for use in vaccines. Immunol Cell Biol 82, 497-505.
17. Munoz, F. M., Piedra, P. A. & Glezen, W. P. (2003). Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 21, 3465-3467.
18. Murphy, B. R., Sotnikov, A., Paradiso, P. R., Hildreth, S. W., Jenson, A. B., Beggs, R. B., Lawrence, L., Zubak, J. J., Chanock, R. M. & other authors (1989). Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine 7, 533-540.
19. Piedra, P. A., Cron, S. G., Jewell, A., Hamblett, N., McBride, R., Palacio, M. A., Ginsberg, R., Oermann, C. M. & Hiatt, P. W. (2003). Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine 21, 2448-2460.
20. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent end points. J Hyg (Lond) 27, 493-497.
21. Russell, C. J., Jardetzky, T. S. & Lamb, R. A. (2001). Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J 20, 4024-4034.
22. Sakurai, H., Williamson, R. A., Crowe, J. E., Beeler, J. A., Poignard, P., Bastidas, R. B., Chanock, R. M. & Burton, D. R. (1999). Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J Virol 73, 2956-2962.
23. Sanders, M. T., Brown, L. E., Deliyannis, G. & Pearse, M. J. (2005). ISCOM-based vaccines: the second decade. Immunol Cell Biol 83, 119-128.
24. Schickli, J. H., Kaur, J., Ulbrandt, N., Spaete, R. R. & Tang, R. S. (2005). An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters. J Virol 79, 10678-10689.
25. Siber, G. R., Leombruno, D., Leszczynski, J., McIver, J., Bodkin, D., Gonin, R., Thompson, C. M., Walsh, E. E., Piedra, P. A. & other authors (1994). Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis 169, 1368-1373.
26. Skiadopoulos, M. H., Biacchesi, S., Buchholz, U. J., Riggs, J. M., Surman, S. R., Amaro-Carambot, E, McAuliffe, J. M., Elkins, W. R., St Claire, M. & other authors (2004). The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol 78, 6927-6937.
27. Skiadopoulos, M. H., Blacchesi, S., Buchholz, U. J., Amaro-Carambot, E., Surman, S. R., Collins, P. L. & Murphy, B. R. (2006). Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345, 492-501.
28. Stills, H. F., Jr (2005). Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J 46, 280-293.
29. Tang, R. S., Mahmood, K., Macphail, M., Guzzetta, J. M., Haller, A. A., Liu, H., Kaur, J., Lawlor, H. A., Stillman, E. A. & other authors (2005). A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23, 1657-1667.
30. Tristram, D. A., Welliver, R. C., Mohar, C. K., Hogerman, D. A., Hildreth, S. W. & Paradiso, P. (1993). Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. J Infect Dis 167, 191-195.
31. Tsui, P., Tornetta, M. A., Ames, R. S., Bankosky, B. C., Griego, S., Silverman, C., Porter, T., Moore, G. & Sweet, R. W. (1996). Isolation of a neutralizing human RSV antibody from a dominant, nonneutralizing immune repertoire by epitope-blocked panning. J Immunol 157, 772-780.
32. Ulbrandt, N. D., Ji, H., Patel, N. K., Riggs, J. M., Brewah, Y. A., Ready, S., Donacki, N. E., Folliot, K., Barnes, A. S. & other authors (2006). Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J Virol 80, 7799-7806.
33. van den Hoogen, B. G., de Jong, J. C., Groan, J., Kuiken, T., de Groot, R., Fouchier, R. A. & Osterhaus, A. D. (2001). A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7, 719-724.
34. van den Hoogen, B. G., Bestebroer, T. M., Osterhaus, A. D. & Fouchier, R. A. (2002). Analysis of the genomic sequence of a human metapneumovirus. Virology 295, 119-132.
35. van den Hoogen, B. G., van Doornum, G. J., Fockens, J. C., Cornelissen, J. J., Beyer, W. E., de Groot R., Osterhaus, A. D. & Fouchier, R. A. (2003). Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 188, 1571-1577.
36. van den Hoogen, B. G., Herfst, S., Sprong, L., Cane, P. A., Forleo, E., de Swart, R. L., Osterhaus, A. D. & Fouchier, R. A. (2004). Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10, 658-666.
37. Walsh, E. E., Hall, C. B., Briselli, M., Brandriss, M. W. & Schlesinger, J. J. (1987). Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis 155, 1198-1204.
38. Williams, J. V., Wang, C. K., Yang, C. F., Tollefson, S. J., House, F. S., Heck J. M., Chu, M., Brown, J. B., Lintao, L. D. & other authors (2006). The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 193, 387-395.